CMS today issued its final National Coverage Determination (NCD) on renal denervation (RDN), a major win for Medtronic and ...

Johnson & Johnson MedTech (NYSE: JNJ) today announced new advances in surgical robotic technology with physical AI ...

Medline announced today that it publicly filed a registration statement with the SEC related to a proposed initial public ...

Pleural Dynamics today announced positive results from a prospective, multicenter study evaluating its ACES device.

AtriCure (Nasdaq:ATRC) announced the first patient enrolled in its BoxX-NoAF clinical trial evaluating its cardiac therapy ...

Orchestra BioMed (Nasdaq:OBIO) announced today that it entered into a termination and right of first refusal agreement with ...

Abbott (NYSE: ABT) reported new study findings supporting the use of its Tendyne transcatheter mitral valve replacement (TMVR ...

Zimmer Biomet (NYSE: ZBH) announced that it received FDA breakthrough device designation for its iodine-treated total hip ...

Remedy Robotics has entered a strategic partnership with the Society of Vascular and Interventional Neurology’s Mission ...

Medtronic today announced the first results from the high cardiovascular risk cohort of its SPYRAL AFFIRM study.

Elixir Medical today announced new landmark clinical results for its DynamX bioadaptor coronary implant system.

Edwards Lifesciences (NYSE: EW) today announced new data demonstrating long-term benefits with its Sapien heart valve system.